Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
NCT02430259
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
566
Enrollment
OTHER
Sponsor class
Conditions
Silicosis
Tuberculosis
Interventions
DRUG:
Weekly INH / RRT given by DOT
Sponsor
Huashan Hospital